Navigation Links
Scottish medical charity and international drug consortium form partnership
Date:1/26/2012

Developing World Health (DWH), a leading medical charity based in Stirlingshire, Scotland and committed to developing effective treatments for neglected tropical diseases, has signed a collaboration agreement with the internationally respected Consortium for Parasitic Drug Development (CPDD), based at The University of North Carolina at Chapel Hill.

The collaboration agreement to develop new drugs is believed to be the first between a UK medical charity and international scientific consortium focused on neglected tropical diseases.

An estimated 16% of the world's population suffer from one or more neglected tropical diseases with 90% of cases recorded in Africa.

The agreement may prove highly lucrative, potentially generating in excess of $15 million investment in drug development for NTDs that urgently need safe and effective new treatments. Referring to the collaboration agreement with CPDD, Dr Stuart WG Smith, Founder and CEO of Scottish medical charity Developing World Health, commented: "Developing World Health's objective is to facilitate the development of new treatments for NTDs. This collaboration will mean that we can expedite the development of novel treatments and help save the lives of many more children and adults afflicted by the scourge of NTD's."

Dr Rick Tidwell, Director of the Consortium for Parasitic Drug Development (CPDD) based at the University of North Carolina at Chapel Hill, commented: "This is a very welcome and exciting strategic partnership and brings together additional expertise to increase funding and collaboration opportunities for the Consortium and enhance the rapid development of novel treatments for NTDs such as African sleeping sickness and leishmaniasis."

The partnership means DWH and CPDD can effectively source funding from commercial, government and not-for-profit organisations to develop and / or improve effective treatments for preventable, treatable diseases like leishmaniasis, African trypanosomiasis (sleeping sickness), Chagas disease (American trypanosomiasis) and Dengue.

The partnership enables the charity to bridge the 'missing link' between academics requiring research funding and the pharmaceutical industry interested in tackling these devastating tropical diseases.

The CPDD currently has in its portfolio, a novel compound shown to be 100% curative in models of late-stage stage African Trypanosomiasis ("sleeping sickness"). This disease is caused by microscopic parasites of the species Trypanosoma brucei and is transmitted by the tsetse fly found only in rural Africa. Currently, about 10,000 new cases each year are reported to the World Health Organization. However, it is believed that many cases go undiagnosed and unreported. Sleeping sickness is fatal if left untreated.

The CPDD brings together some of the world's top experts in drug development and delivery from UNC-Chapel Hill, Georgia State University, the University of Glasgow, Ohio State University, the Swiss Tropical Institute, and the Kenya Trypanosomiasis Research Institute among others.


'/>"/>

Contact: Colin Hutchison
chutchison@3x1.com
44-131-225-7700
University of North Carolina School of Medicine
Source:Eurekalert

Related medicine news :

1. Wild Scottish sheep could help explain differences in immunity
2. Heart disease study highlights Scottish ethnic groups most at risk
3. TheReliefPlace.com Launches Online Store “The Relief Shop” - What Does this Medical Supply Store Carry and How Can They Help You?
4. Medical Transcription Services and EHR Provider MxSecure Launches New Enhanced Website with Goal of Improved Physician Productivity
5. Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program
6. FDA Seeks Reduction in Radiation From Medical Scans
7. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
8. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
9. Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements
10. Centene Corporation Hosts Medical Management Systems Update in New York City
11. CelebrityDiagnosis.com Nominated as Best New Medical Blog of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... The Aesthetic Channel has recently highlighted ... has come up with a proprietary technique that he calls the AuraLyft ... dropped. For all ages, patients can expect to look refreshed, rejuvenated, and revitalized. ...
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased to announce that California ... members. As part of the amalgam separator endorsement, all CDA members may purchase an ... off the retail value. This partnership between PureLife and CDA is especially timely as ...
(Date:6/23/2017)... ... June 23, 2017 , ... Jusino Insurance ... to communities in the greater Chicago metropolitan area, is embarking on a charity ... youth in Chicago. , Founded in 1897, Hephzibah Children’s Association is one of ...
(Date:6/22/2017)... Rosa, CA (PRWEB) , ... June 22, 2017 , ... ... been named as a Top Doctor for 2017. Each year, research and information firm, ... country. First winning the title in 2015, this marks the 3rd time that ...
(Date:6/22/2017)... ... 2017 , ... The VA Maryland Health Care System has ... the Baltimore VA Medical Center, a division of the VA Maryland Health Care ... promote waste reduction and promote recycling. Also, Practice Greenhealth has recognized the ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... HAMPTON, Va. , June 14, 2017  ivWatch ... safety and effectiveness of intravenous (IV) therapy, is pleased ... in the category of Nonsurgical Hospital Supplies and Equipment ... premier awards program for the medtech industry. The award ... at the Jacob K. Javits Center in ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company ... from three Phase 3 studies of galcanezumab, an investigational ... including late-breaking data on several key secondary endpoints for ... results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will ... annual scientific meeting in Boston . ...
(Date:6/8/2017)... 2017   Responding to Heath Ledger,s father,s ... of singer Chris Cornell in May, the mental ... a free online psychiatric drug side effects ... about psychotropic drug risks. The father of ... an accidental overdose, has called for tighter rules on prescription ...
Breaking Medicine Technology: